This reinforces the need to refine the integration of PD‐L1 and TILs as biomarkers, potentially incorporating them into multiparametric models that account for the interplay between intrinsic tumor biology and host immunity, to better predict outcomes and guide treatment decisions in TNBC [22, 25]. Here, CD274 is linked to neoplasm.